The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
- 1 April 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57, S7-S14
- https://doi.org/10.1046/j.1523-1755.2000.07509.x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Angiotensin II and gene expression in the kidneyAmerican Journal of Kidney Diseases, 1998
- Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.Journal of Clinical Investigation, 1997
- Tumor Necrosis Factor Activates Angiotensinogen Gene Expression by the Rel A TransactivatorHypertension, 1996
- Mechanisms for Inducible Control of Angiotensinogen Gene TranscriptionHypertension, 1996
- Increased Gene Expression of Insulin-Like Growth Factor-I Receptor in Experimental Diabetic Rat GlomeruliNephron, 1996
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretionKidney International, 1992
- Tumor necrosis factor alpha and mesangial cellsKidney International, 1992
- The Progression of Renal DiseaseNew England Journal of Medicine, 1988